• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 471/12 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed system contains three hetero rings

Patent holdings for IPC class C07D 471/12

Total number of patents in this class: 178

10-year publication summary

19
19
8
5
10
9
17
11
10
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Janssen Pharmaceutica N.V.
3610
11
Merck Patent GmbH
5864
5
Senhwa Biosciences, Inc.
43
5
LG Chem, Ltd.
17662
4
ChemoCentryx, Inc.
392
4
Bristol-myers Squibb Company
4864
3
BASF SE
20501
3
Syngenta Participations AG
3029
3
Takeda Pharmaceutical Company Limited
2946
3
Intra-Cellular Therapies, Inc.
393
3
Oncoceutics, Inc.
30
3
Owens Corning Intellectual Capital, LLC
1565
3
Tel Hashomer Medical Research Infrastructure and Services Ltd.
334
3
Neuron23, Inc.
22
3
Novartis AG
11234
2
Coley Pharmaceutical Group, Inc.
52
2
Abbvie Inc.
1786
2
BeiGene, Ltd.
353
2
Deciphera Pharmaceuticals, LLC
201
2
Eli Lilly and Company
3734
2
Other owners 110